38426-11-8

Basic information

• Product Name: 2-Chloro-N-(4-nitro-benzyl)-acetaMide
• Synonyms: 2-Chloro-N-(4-nitro-benzyl)-acetaMide
• CAS NO: 38426-11-8
• Molecular Formula: C₉H₉ClN₂O₃
• Molecular Weight: 228.63236
• Mol File: 38426-11-8.mol
• Article Data: 4

Chemical Properties

• Melting Point: 113-114 °C
• Boiling Point: 474.6°Cat760mmHg
• Flash Point: 240.8°C
• Appearance: /
• Density: 1.361g/cm³
• Vapor Pressure: 3.57E-09mmHg at 25°C
• Refractive Index: 1.574
• PKA: 12.93±0.46(Predicted)
• CAS DataBase Reference: 2-Chloro-N-(4-nitro-benzyl)-acetaMide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-N-(4-nitro-benzyl)-acetaMide(38426-11-8)
• EPA Substance Registry System: 2-Chloro-N-(4-nitro-benzyl)-acetaMide(38426-11-8)

Safety Data

• Hazardous Substances Data: 38426-11-8(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H9ClN2O3/c10-5-9(13)11-6-7-1-3-8(4-2-7)12(14)15/h1-4H,5-6H2,(H,11,13)

Upstream product

• 7409-30-5 p-nitrobenzylamine 
• 79-04-9 chloroacetyl chloride 

Downstream Products

• 1429436-85-0 C₁₆H₁₄N₄O₃S₂ 

Relevant articles and documents

Lead Optimization and Structure-Activity Relationship Studies on Myeloid Ecotropic Viral Integration Site 1 Inhibitor

The pivotal role of the myeloid ecotropic viral integration site 1 (MEIS1) transcriptional factor was reported in cardiac regeneration and hematopoietic stem-cell (HSC) regulation with our previous findings. MEIS1 as a promising target in the context of p

Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening

Inhibition of the signal transducer and activator of transcription 3 (STAT3) signaling pathway has been considered a novel therapeutic strategy to treat human cancers that harbor aberrantly-active STAT3. In this study, nearly 204,000 compounds in Specs database were screened by virtual screening, and samples of top 100 compounds identified as candidate small-molecule inhibitors of STAT3 were evaluated by STAT3-dependent luciferase reporter assay as well as other cell-based assays. A benzothiazole core scaffold containing compound, 9, was identified as an inhibitor of IL-6/STAT3 signaling with an IC50 of 3.567 μM. It is the first time to discover benzothiazole scaffold as a potent STAT3 signaling inhibitor. We further investigated the (structure-activity relationship) SAR of the benzothiazole analogues, and discovered compound 16w as a better small-molecule inhibitor. Both compounds inhibited the phosphorylation of STAT3 and had no obvious effect on upstream JAK2 kinase.